The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Antibodies, Bispecific.
Andrzej Jakubowiak
Connection Strength
0.055
Antibodies, Bispecific
  1. Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent. Adv Ther. 2026 01; 43(1):333-355.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.